EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and evaluation of rectal suppository formulation for antidiabetic activity of repaglinide: A comparative study

Asiya Asal Khan, Abdul Baseer, Kamran Hidayat Ullah, Munair Badshah, Abdur Rahim, Jehan Zeb Khan, Jawad Khan, Hamid Iqbal

Letters in Drug Design & Discovery · 2026-02 · 23 (2) · 100392

DOI: 10.1016/j.lddd.2026.100392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-02. Verfasst von Asiya Asal Khan und 7 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Khan, A. A., Baseer, A., Ullah, K. H., Badshah, M., Rahim, A., Khan, J. Z., Khan, J., & Iqbal, H. (2026). Development and evaluation of rectal suppository formulation for antidiabetic activity of repaglinide: A comparative study. Letters in Drug Design & Discovery, 23(2), 100392. https://doi.org/10.1016/j.lddd.2026.100392

Vancouver

Khan AA, Baseer A, Ullah KH, Badshah M, Rahim A, Khan JZ, et al. Development and evaluation of rectal suppository formulation for antidiabetic activity of repaglinide: A comparative study. Letters in Drug Design & Discovery. 2026;23(2):100392. doi:10.1016/j.lddd.2026.100392

BibTeX
@article{Khan2026,
  author = {Khan, Asiya Asal and Baseer, Abdul and Ullah, Kamran Hidayat and Badshah, Munair and Rahim, Abdur and Khan, Jehan Zeb and Khan, Jawad and Iqbal, Hamid},
  title = {Development and evaluation of rectal suppository formulation for antidiabetic activity of repaglinide: A comparative study},
  journal = {Letters in Drug Design & Discovery},
  year = {2026},
  volume = {23},
  number = {2},
  pages = {100392},
  doi = {10.1016/j.lddd.2026.100392}
}
Kostenlos starten →